Zobrazeno 1 - 10
of 517
pro vyhledávání: '"Gianenrico, Senna"'
Autor:
Marco Caminati, MD, Lucia Federica Carpagnano, MD, Chiara Alberti, MSc, Francesco Amaddeo, PhD, Riccardo Bixio, MD, Federico Caldart, MD, Lucia De Franceschi, PhD, Micol Del Giglio, PhD, Giuliana Festi, MD, Simonetta Friso, PhD, Luca Frulloni, MD, Paolo Gisondi, MD, Mauro Krampera, PhD, Giuseppe Lippi, PhD, Claudio Micheletto, MD, Giorgio Piacentini, PhD, Patrick Pinter, MD, Maurizio Rossini, PhD, Michele Schiappoli, MD, Cristina Tecchio, PhD, Laura Tenero, PhD, Elisa Tinazzi, PhD, Gianenrico Senna, MD, Matilde Carlucci, MD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100928- (2024)
Hypereosinophilic syndromes (HES) represent a group of rare dis-immune conditions characterized by blood hyper-eosinophilia and eosinophilic related burden. Especially the idiopathic subtype (I-HES) is particularly difficult to diagnose because of it
Externí odkaz:
https://doaj.org/article/dbbf5baf061344db9728a002cad44571
Autor:
Marco Caminati, MD, Alessandro Marcon, PhD, Rachele Vaia, MD, Gianenrico Senna, MD, Matteo Maule, MD, Pierpaolo Marchetti, MD, Jessica Miotti, MD, Giuseppe Argentino, MD, Francesco Blasi, MD, PhD, Giorgio W. Canonica, MD, Enrico M. Heffler, MD, PhD, Pierluigi Paggiaro, MD, Andrea Vianello, MD, PhD, Gabriella Guarnieri, MD, Luisa Brussino, MD PhD, S.S.D.D.U, Cecilia Calabrese, MD PhD, Gianna Camiciottoli, MD, Giovanna E. Carpagnano, MD PhD, Stefano Centanni, MD PhD, Angelo G. Corsico, MD PhD, Maria T. Costantino, MD, Claudia Crimi, MD PhD, Alice D'adda, MD, Simona D'alo, MD, Maria D'amato, MD PhD, Stefano Del Giacco, MD, Fabiano Di Marco, MD PhD, Nicola C. Facciolongo, MD, Manuela Latorre, MD PhD, Eustachio Nettis, MD, Eleonora Nucera, MD, Giovanni Passalacqua, MD, Girolamo Pelaia, MD, Laura Pini, MD PhD, Luisa Ricciardi, MD, Luca Richeldi, MD, Erminia Ridolo, MD PhD, Pierachille Santus, MD PhD, Nicola Scichilone, MD, Giulia Scioscia, MD PhD, Giuseppe Spadaro, MD, Antonio Spanevello, MD PhD, Paolo Tarsia, MD PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100941- (2024)
Background: Aging implies changes in terms of lung function, immune system, and respiratory and extra-respiratory comorbidities. Few studies have specifically addressed the relevance of age on severe asthma burden and control. We aimed to evaluate wh
Externí odkaz:
https://doaj.org/article/9826bfd798df48a19f3413facbb54880
Autor:
Gabriella Guarnieri, Bianca Olivieri, Manuela Latorre, Angela Rizzi, Francesco Blasi, Giorgio Walter Canonica, Enrico Heffler, Pierluigi Paggiaro, Gianenrico Senna, Marco Caminati
Publikováno v:
European Clinical Respiratory Journal, Vol 11, Iss 1 (2024)
Objective Initiated by the Severe Asthma Network Italy (SANI), this study aims to explore asthma patients’ perceptions of disease severity, differentiating between mild and severe asthma. The objective is to identify factors influencing tailored tr
Externí odkaz:
https://doaj.org/article/6501b9ac351f4bb596c3ac928d865be4
Autor:
Francesco Menzella, Sara Munari, Lorenzo Corsi, Silvia Tonin, Walter Cestaro, Andrea Ballarin, Ariel Floriani, Cristina Dartora, Gianenrico Senna
Publikováno v:
Journal of International Medical Research, Vol 52 (2024)
Asthma is a disease characterised by heterogeneous and multifaceted airway inflammation. Despite the availability of effective treatments, a substantial percentage of patients with the type 2 (T2)-high, but mainly the T2-low, phenotype complain of pe
Externí odkaz:
https://doaj.org/article/a6369c564919441f8d7a62f68a080f74
Autor:
Marco Caminati, Luisa Brussino, Matilde Carlucci, Palma Carlucci, Lucia Federica Carpagnano, Cristiano Caruso, Lorenzo Cosmi, Simona D’Amore, Stefano Del Giacco, Aikaterini Detoraki, Mario Di Gioacchino, Andrea Matucci, Ilaria Mormile, Francescopaolo Granata, Gabriella Guarnieri, Mauro Krampera, Matteo Maule, Eustachio Nettis, Stefania Nicola, Silvia Noviello, Fabrizio Pane, Cristina Papayannidis, Paola Parronchi, Girolamo Pelaia, Erminia Ridolo, Francesca Wanda Rossi, Gianenrico Senna, Massimo Triggiani, Angelo Vacca, Emanuele Vivarelli, Alessandra Vultaggio, Amato de Paulis
Publikováno v:
Cells, Vol 13, Iss 14, p 1180 (2024)
Hypereosinophilic syndrome (HES) encompasses a heterogeneous and complex group of different subtypes within the wider group of hypereosinophilic disorders. Despite increasing research interest, several unmet needs in terms of disease identification,
Externí odkaz:
https://doaj.org/article/38b0cb2c3abe4ef3b645f47ffe42dbb7
Autor:
Paul J. Turner, MD, PhD, Ignacio J. Ansotegui, MD, PhD, Dianne E. Campbell, MD, PhD, Victoria Cardona, MD, PhD, Stuart Carr, MD, Adnan Custovic, MD, PhD, Stephen Durham, MD, Motohiro Ebisawa, MD, PhD, Mario Geller, MD, Alexei Gonzalez-Estrada, MD, Paul A. Greenberger, MD, Elham Hossny, MD, PhD, Carla Irani, MD, Agnes S.Y. Leung, MD, Michael E. Levin, MD, PhD, Antonella Muraro, MD, John J. Oppenheimer, MD, José Antonio Ortega Martell, MD, Guillaume Pouessel, MD, Manuel J. Rial, MD, PhD, Gianenrico Senna, MD, PhD, Luciana K. Tanno, MD, PhD, Dana V. Wallace, MD, Margitta Worm, MD, PhD, Mário Morais-Almeida, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 3, Pp 100876- (2024)
There is a lack of consensus over the description and severity assignment of allergic adverse reactions to immunotherapy, although there seems to be a consensus at least in terms of using the World Allergy Organization (WAO) grading systems to descri
Externí odkaz:
https://doaj.org/article/57404339065d440791e5ca78fb04f075
Autor:
Marco Caminati, Matteo Maule, Roberto Benoni, Claudio Micheletto, Cristina Tecchio, Rachele Vaia, Lucia De Franceschi, Gabriella Guarnieri, Andrea Vianello, Gianenrico Senna
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-6 (2023)
Abstract Mepolizumab at the dose of 300 mg/4 weeks has been recently approved as an add-on therapy for patients with uncontrolled hypereosinophilic syndrome (HES) without any identifiable non-hematologic secondary cause. According to the available re
Externí odkaz:
https://doaj.org/article/6ec1f65ac355458bad58e3b391114afa
Autor:
Laura Pini, Diego Bagnasco, Bianca Beghè, Fulvio Braido, Paolo Cameli, Marco Caminati, Cristiano Caruso, Claudia Crimi, Gabriella Guarnieri, Manuela Latorre, Francesco Menzella, Claudio Micheletto, Andrea Vianello, Dina Visca, Benedetta Bondi, Yehia El Masri, Jordan Giordani, Andrea Mastrototaro, Matteo Maule, Alessandro Pini, Stefano Piras, Martina Zappa, Gianenrico Senna, Antonio Spanevello, Pierluigi Paggiaro, Francesco Blasi, Giorgio Walter Canonica, on behalf of the SANI Study Group
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 10, p 3013 (2024)
Background: Benralizumab has been shown to restore good control of severe eosinophilic asthma (SEA). Robust data on benralizumab effectiveness over periods longer than 2 years are scarce. Methods: This retrospective multicentric study was conducted o
Externí odkaz:
https://doaj.org/article/2a5397c1b8144023b9fc291eadfa6b08
Autor:
Diego Bagnasco, Benedetta Bondi, Marco Caminati, Stefania Nicola, Laura Pini, Manlio Milanese, Luisa Brussino, Gianenrico Senna, Giorgio Walter Canonica, Fulvio Braido
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 960 (2024)
Background: In its severe form, where possible, asthma is treated using biological drugs in order to reduce, as much as possible, the use of systemic steroids. Mepolizumab is effective for severe asthma based on key outcomes such as exacerbation and
Externí odkaz:
https://doaj.org/article/3d265a7a68614149aea5944e49d79a90
Autor:
Alessandra Vultaggio, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Maria D’Amato, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Marco Benci, Silvia Boarino, Jan Walter Schroeder
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background The efficacy of benralizumab has been broadly demonstrated in severe eosinophilic asthma (SEA), but only few real-life studies evaluated its long-term effects. Here we present novel data from the ANANKE study in which a large coho
Externí odkaz:
https://doaj.org/article/28c6788b881f4a95a1719795987231a7